VISINE A.C. ITCHY EYE RELIEF- tetrahydrozoline hydrochloride and zinc sulfate, unspecified form solution/ drops 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Visine® A.C. Itchy Eye Relief

Drug Facts

Active ingredientsPurpose
Tetrahydrozoline HCl 0.05%Redness reliever
Zinc sulfate 0.25%Astringent

Use

Warnings

For external use only

Ask a doctor before use if you have narrow angle glaucoma.

When using this product

  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using
  • do not use if this solution changes color or becomes cloudy
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use
  • some users may experience a brief tingling sensation

Stop use and ask a doctor if

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium chloride, sodium citrate

Questions?

call toll-free 888-734-7648 or 215-273-8755 (collect)

Distributed by: JOHNSON & JOHNSON CONSUMER INC. Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

VISINE®

A.C.
ITCHY EYE RELIEF

ASTRINGENT /
REDNESS RELIEVER EYE DROPS

RELIEVES ITCHY, RED,
WATERY EYES

STERILE
1/2 FL OZ (15mL)

Principal Display Panel - 15 mL Bottle Carton
VISINE A.C. ITCHY EYE RELIEF 
tetrahydrozoline hydrochloride and zinc sulfate, unspecified form solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69968-0366
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TETRAHYDROZOLINE HYDROCHLORIDE (UNII: 0YZT43HS7D) (TETRAHYDROZOLINE - UNII:S9U025Y077) TETRAHYDROZOLINE HYDROCHLORIDE0.5 mg  in 1 mL
ZINC SULFATE, UNSPECIFIED FORM (UNII: 89DS0H96TB) (ZINC CATION - UNII:13S1S8SF37) ZINC SULFATE, UNSPECIFIED FORM2.5 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
WATER (UNII: 059QF0KO0R)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69968-0366-11 in 1 CARTON05/06/2019
115 mL in 1 BOTTLE; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34905/06/2019
Labeler - Johnson & Johnson Consumer Inc. (118772437)

Revised: 1/2023
Document Id: ee86a572-acb1-7a48-e053-2995a90aa347
Set id: 257b9666-0163-499b-9673-bf6f4d6899b1
Version: 2
Effective Time: 20230103
 
Johnson & Johnson Consumer Inc.